All posts tagged: Future Medicine

  1. home
  2. blog
  3. Future Medicine

Cannabidiol May Provide Novel Treatment for Rare Ovarian Cancer

June 27, 2019 , , , , , , , , , , , ,

Dramatic response to Laetrile and cannabidiol (CBD) oil in a patient with metastatic low grade serous ovarian carcinoma

A recent case study has examined a patient’s response to the consumption of cannabidiol (CBD) as a treatment for a rare type of ovarian cancer. Rather than participate in chemotherapy, which has been shown to only be effective in 5% of patients with low grade serous ovarian carcinoma, an 81-year-old decided to take a combination of amygdalin and CBD. Although CBD has only been shown to have effective anti-cancer properties in murine models the featured patient reported a significant decrease in tumor size, revealing that CBD may, in fact, be an effective treatment for patients looking into alternative care methods.

Although proven ineffective, the use of amygdalin highlights alternative therapies derived from naturally occurring chemicals found in common plants. Flavonoids and terpenes are chemical components of cannabis plants, also found in a variety of fruits and vegetables, that are just now being investigated for their therapeutic benefits. The results of those inquiries may prove useful for similar patients suffering from illnesses that are resistant to the usual treatments.

View this review (yellow link) or download:

Dramatic response to Laetrile and cannabidiol (CBD) oil in a patient with metastatic low grade serous ovarian carcinomaDownload

This paper is also stored here:   http://bit.ly/2L9pCJZ      inside the CED Foundation Archive

To explore related information, click the keywords below:

Benjamin Caplan, MDCannabidiol May Provide Novel Treatment for Rare Ovarian Cancer
read more

Medical vs Rec

June 26, 2019 , , , , , , , , , ,

Many think medical marijuana laws will ultimately lead to adult-use, but this is not necessarily true, and for good reason. The medical industry recognizes that cannabis is a powerful medication and prioritizes its safety and health benefits, while so-called “recreational” or “adult use” cannabis seems to focus more on making money and supporting the pleasurable aspects of the plant.

Interestingly, at CED Clinic, we’re seeing more and more patients come in from the “adult-use.” Whether it’s a desire for comprehensive education (anything we put into our bodies has effects), personalizing a medical plan that considers short-term and long-term impact, or simply having a knowledgeable person to support individual choices and empowerment on an individual journey, we find that our patients enjoy learning and riding the cutting edge of the science of cannabis! http://bit.ly/2INDGY7

To explore related information, click the keywords below:

Benjamin Caplan, MDMedical vs Rec
read more

In MA, despite being state-legal, FDA says CBD cannot be added to food or dietary supplements. What now?

June 26, 2019 , , , , , , , , , , , , , ,

MA effectively outlawed the sale of any food products with CBD or products which make therapeutic claims. This is the result of FDA saying that CBD cannot be added to food or dietary supplements. In a state where cannabis is legally accessible, consumers and hemp farmers are very unhappy. What do you think? http://bit.ly/2IOtTRm

Benjamin Caplan, MDIn MA, despite being state-legal, FDA says CBD cannot be added to food or dietary supplements. What now?
read more

Cannabis Cafes coming to MA

June 26, 2019 , , , , , , , , , , , , ,

Massachusetts has come one step closer to a pilot program involving cannabis cafes across the state. This will also bring about more licenses for cannabis delivery and social consumption, as a less capital-intensive option for entrepreneurs to enter the industry. http://bit.ly/2IOjOUz

To explore related information, click the keywords below:

Benjamin Caplan, MDCannabis Cafes coming to MA
read more

Case Studies Reveal Difficulties in Differences between State Cannabis Laws

June 26, 2019 , , , , , , , , , , , , ,

Crossing the Line: Care of a Pediatric Patient with Intractable Seizures and Severe Neuropathic Pain in Absence of Access to Medical Marijuana

A recent case report discussing a six-year-old patient suffering from a seizure disorder has exposed the difficulty is receiving treatment across state lines. The patient was prescribed medical marijuana that alleviated the severity and duration of her seizures but was weaned off that medication when traveling to Nebraska for a therapeutic surgery due to the legal status in the state. This case study exposes the difficulty of treating patients across the country due to the legal variability of cannabis across states.  

An interesting question brought up in this case study is how to handle palliative care in the absence of opioids and without synthetic products. A combination of massage, essential oils, and salt light therapies were able to compensate for medical marijuana, but not without great effort. Natural therapies like the ones administered here are costly and highlight the simplicity and effectiveness of medicinal cannabis.

View this review (yellow link) or download:

Crossing the Line: Care of a Pediatric Patient with Intractable Seizures and Severe Neuropathic Pain in Absence of Access to Medical MarijuanaDownload

This paper is also stored here:   http://bit.ly/2IxPoWN      inside the CED Foundation Archive

To explore related information, click the keywords below:

Benjamin Caplan, MDCase Studies Reveal Difficulties in Differences between State Cannabis Laws
read more

Video: The Endocannabinoid System’s Intriguing Role in Gut Health

June 26, 2019 , , , , , , , , , , , , , , , , , ,

A 2018 literature review summarizes the findings on cannabis and gut health. The endocannabinoid system plays a key role in gut motility, obesity, and inflammatory bowel disease (IBD). Targeting the endocannabinoid system with CBD oil or other cannabinoids seems to reduce colonic inflammation and relieve stress, at a microscopic level, inside the gastrointestinal tract. Watch our video adaptation of the effects of cannabis on IBD:

View this review (yellow link) or download:

The Endocannabinoid System’s Intriguing Role in Gut HealthDownload

This paper is also stored here:    http://bit.ly/2IQCNy1     inside the CED Foundation Archive

To explore related information, click the keywords below:

Benjamin Caplan, MDVideo: The Endocannabinoid System’s Intriguing Role in Gut Health
read more

CBD antibacterial properties, topically

June 25, 2019 , , , , , , , , , , , , , ,

Preliminary testing shows positive results towards using CBD as an antibiotic topically, but also potentially to deal with systematic infections, such as pneumonia, using oral dosing. One of the present concerns is the struggle of getting permits to handle these cannabinoids to do further testing.

While these specific findings have not yet been published in a peer-review journal, this is far from the first time we have seen antimicrobial activity associated with plants or with cannabis. Evolutionarily, this trait is believed to be adaptive for the plant, and within cannabinoid, terpenoid, and flavonoid compounds, this activity has been demonstrated reproducibly, both in the lab and in clinic.
http://bit.ly/2LbTwxm

To explore related information, check the CED Foundation MMJ archive to search, or click the keywords below:

Benjamin Caplan, MDCBD antibacterial properties, topically
read more

Massachusetts patients Initial Access option

June 25, 2019 , , , , , , , ,

Exciting note to Massachusetts medical cannabis patients: Beginning July 1, medical patients will have the opportunity for an “Initial Access Certification” once they have seen their certifying physician.
This access is good for 14 days, so patients will no longer have to wait for the state approval process before having access to medication.
More info: http://bit.ly/2LmFY1Q

View the full documentation (yellow link) or download:

Initial Access Info for PatientsDownload
Benjamin Caplan, MDMassachusetts patients Initial Access option
read more